<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3685283/" ref="ordinalpos=5000&amp;ncbi_uid=5258462&amp;link_uid=PMC3685283" image-link="/pmc/articles/PMC3685283/figure/F5/" class="imagepopup">Figure 5.  From: INHIBITION OF THE HEDGEHOG <span class="highlight" style="background-color:">PATHWAY</span> TARGETS THE TUMOR-ASSOCIATED STROMA IN PANCREATIC CANCER. </a></div><br /><div class="p4l_captionBody">Hh pathway signaling in PDAC in vitro and in vivo. (A) Quantitative PCR for Gli1 expression. HPSC-GFP cells were cultured with or without Bxpc3 for 96 hours and sorted by flow cytometry. ** p&lt;0.0001. Immunohistochemistry for Ki67 (B) and CD31 (C) was performed on mouse pancreatic tumors with tumor/stroma ratio 1:3 treated with AZD8542 or control. Total magnification 100X. Data is shown as means Â± SEM;* p&lt;0.005 and ** p&lt;0.0001.</div></div>